Benjamin Kovachy
Harvard University
5 Papers
1 Citations
Benjamin Kovachy is an academic researcher from Harvard University. The author has contributed to research in topics: Psychopathology & Randomized controlled trial. The author has an hindex of 3, co-authored 5 publications.
Chat about Author
Papers
Peritraumatic distress: A review and synthesis of 15 years of research.
TL;DR: Peritraumatic distress is associated with PTSD symptom severity, other psychiatric symptoms, and severity of PTSD-related symptoms after exposure to non-Criterion A stressful events by DSM-5 criteria, suggesting that peritraumat distress is a risk factor for various psychiatric outcomes.
Corrigendum to “Telomere length and telomerase in a well-characterized sample of individuals with major depressive disorder compared to controls” [Psychoneuroendocrinology 58 (2015) 9–22]
Naomi M. Simon,Zandra E. Walton,Eric Bui,Jennifer Prescott,Elizabeth A. Hoge,Aparna Keshaviah,Noah Schwarz,Taylor Dryman,Rebecca A. Ojserkis,Benjamin Kovachy,David Mischoulon,John J. Worthington,Immaculata DeVivo,Immaculata DeVivo,Maurizio Fava,Kwok-Kin Wong +15 more
TL;DR: In this article, Simona et al. compared the telomere length and telomerase in individuals with major depressive disorder compared to controls, and found that the latter was significantly worse than the former.
1
Randomized Controlled Trial of Sertraline, Prolonged Exposure Therapy and Their Combination in OEF/OIF with PTSD
Sheila A. M. Rauch,Margaret R. Venners,Katherine E. Porter,Israel Liberzon,Luan Phan,Brian Martis,Anthony P. King,Murray B. Stein,Carolyn B. Allard,Sonya B. Norman,Mark West,Ron Acierno,Peter Tuerk,Mark B. Hamner,Hugh Myrick,Michelle Pompei,Linette Dubois,Naomi M. Simon,Andrew H. Rogers,Benjamin Kovachy +19 more
- 01 Dec 2011
TL;DR: The current proposal aims to directly compare the psychotherapy and medication treatments for PTSD considered to have the most evidence for effectiveness, and to examine psychological and neurobiological predictors of response to treatment and mechanisms of change during treatment (pre to post treatment change).
Telomere length and telomerase in a well-characterized sample of individuals with major depressive disorder compared to controls.
Naomi M. Simon,Zandra E. Walton,Eric Bui,Jennifer Prescott,Elizabeth A. Hoge,Aparna Keshaviah,Noah Schwarz,Taylor Dryman,Rebecca A. Ojserkis,Benjamin Kovachy,David Mischoulon,John J. Worthington,Immaculata DeVivo,Immaculata DeVivo,Maurizio Fava,Kwok-Kin Wong +15 more
TL;DR: A well-characterized, well-powered examination of concurrently assessed telomere length and telomerase activity in individuals with clinically significant, chronic MDD and matched controls failed to provide strong evidence of an association of MDD with shorter LTL, while telomersase activity was higher in men with MDD.
Prospective association between major depressive disorder and leukocyte telomere length over two years.
Mary C. Vance,Eric Bui,Susanne S. Hoeppner,Benjamin Kovachy,Jennifer Prescott,David Mischoulon,Zandra E. Walton,Melissa Dong,Mireya Nadal,John J. Worthington,Elizabeth A. Hoge,Paolo Cassano,Esther H. Orr,Maurizio Fava,Immaculata De Vivo,Kwok-Kin Wong,Naomi M. Simon +16 more
TL;DR: A baseline diagnosis of MDD prospectively predicted LTL shortening over two years, providing further support for MDD as a disease associated with accelerated aging in a well-characterized sample using validated, clinician-rated measures.